Deficiency of a family of three leukocyte adhesion molecules (Leu-CAM) is associated with recurrent and life-threatening bacterial infections in man. Each of the three antigens, Mol, LFA-1, and Len M5 has a distinct alpha subunit noncovalently associated with a common beta subunit that appears to be required for the expression of these antigens on the cell surface.
Introduction
Among the basic biologic functions ofleukocytes are chemotaxis, phagocytosis, cell-mediated cytotoxicity, and natural killing. That these apparently unrelated functions are in fact mediated by a family of related cell surface molecules has been established through the identification ofa number ofpatients suffering from recurrent and life-threatening bacterial infections whose leukocytes exhibit abnormalities in adhesion-dependent functions such as phagocytosis, chemotaxis, adhesion to endothelial cell monolayers, cell-mediated cytotoxicity, and natural killing (reviewed in ref. 1) . Leukocytes from these patients either lack or have markedly reduced levels of three antigens on the surface ofcirculating leukocytes (2, 3) . These three glycoproteins, named Mol, LFA-1, and Leu M5 (p 150, 95) are heterodimers, each consisting of a distinct alpha subunit (155, 175, and 140 kD, respectively) noncovalently linked to a common beta subunit of94 kD (4) (5) (6) . Amino acid sequencing ofthese purified proteins and nucleotide sequencing ofcDNA clones revealed remarkable homologies with other cell adhesion molecules such as the fibronectin receptor and the platelet IIb/IIIa complex (7, 8) . Mol and Leu M5 are expressed on monocytes, granulocytes, and null cells, whereas LFA-1 is present, in addition, on T and B lymphocytes (4) (5) (6) . Monoclonal antibodies (MAbs)' directed against this family of molecules reproduce on normal cells the defects seen in genetically deficient leukocytes (1, 2).
Leu-CAM deficiency is an inherited disorder. In most families, leukocytes from both parents have -50% ofnormal levels of Leu-CAM antigens suggesting an autosomal basis for this disease. In other cases, the pattern of inheritance suggests an Xlinked disorder (9) . In yet other families, the mode of inheritance is less certain (10, 11) .
The molecular basis for Leu-CAM deficiency is unclear. Two recent studies demonstrated that metabolically labeled leukocytes from patients suffering from partial or complete Leu-CAM deficiency synthesize the alpha subunits but not the beta subunit of Leu-CAM and concluded that the disease is secondary to a primary deficiency of the common beta subunit (12, 13) . These findings, however, could not explain the phenotypic variation in Leu-CAM surface expression among affected patients.
In this report, we investigated the molecular basis of Leu-CAM deficiency in four unrelated patients with either the partial or complete forms of the disease. Lymphocytes from all four patients synthesized normal amounts of a beta subunit precursor that either failed to mature or only partially matured to the 94-kD surface membrane expressed form. RNA extracted from all four patients' leukocytes contained a single species of ft subunit mRNA of 3.4 kD similar in mobility to that present in normal cells. We conclude that Leu-CAM deficiency in these four patients is not due to a lack of the beta subunit gene, but to a defect affecting the posttranslational processing of a beta chain precursor. This defect could result from distinct mutation(s) in the structural beta subunit gene leading to synthesis ofabnormal beta chains, which may vary in their capacity to form alphabeta complexes. This could result in the quantitative differences in Leu-CAM surface membrane expression observed in this disorder.
1. Abbreviations used in this paper: EBV, Epstein-Barr virus; MAbs, monoclonal antibodies; PAGE, polyacrylamide gel electrophoresis; PMSF, phenylmethylsulfonyl fluoride.
Methods
Subjects. We studied four unrelated patients with Leu-CAM deficiency and three normal subjects. The clinical history, pathologic findings and Leu-CAM phenotypes in all four patients have been reported (2, 9, 10, 14) . Immunofluorescence analysis (Fig. 1 A rabbit polyclonal antibody directed against the beta subunit was developed as follows: Human Mol was purified from granulocytes by Lentil lectin Sepharose chromatography followed by affinity chromatography on a monoclonal anti-Mol Sepharose column (7) (Fig. 2 A) . Following sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE) the beta subunit was electroeluted (18) (Fig. 2 A) , emulsified in complete Freund's adjuvant and injected subcutaneously into rabbits. After two boosts, in incomplete Freund's adjuvant, animals were bled, and the IMMUNOFLUORESCENCE (Log)- Figure 1 . Immunofluorescence analysis of EBV-transformed B cells from three controls (C1-3) and four patients with Leu-CAM deficiency. Cells were stained with TS18 (anti-beta chain monoclonal antibody) or with a nonreactive mouse monoclonal antibody as previously described (2) . Data are presented as single parameter histograms. The x-axis represents relative fluorescence intensity (256 channel resolution; log. scale). For quantitative comparisons, the mean peak channel of the fluorescence was converted into a linear value (neg. control assigned 10) as indicated in arabic numerals, using a calibration factor. #2-Microglobulin-dependent peak channel fluorescence (arbitrary units) on leukocytes from patients 1-4 were 301, 348, 332, and 261, respectively, compared with 249, 249, and 300 for controls C1-3, respectively. 40% ammonium sulfate cut was used for immunoprecipitations. Immunoprecipitations from 125I-surface labeled monocytes using TS18 monoclonal antibody and rabbit anti-beta subunit antibody followed by SDS-PAGE revealed that both antibodies immunoprecipitate the beta chain of the Leu-CAM complex (Fig. 2 B) . Furthermore Enzyme Center Inc., Malden, MA). The precleared lysate was then incubated with 45 Ml of purified polyclonal anti-beta subunit antibody (15 mg/ml) or with a nonimmune rabbit Ig overnight at 4VC. 200 Ml of 10% G-sorb was washed, pelleted then added to the mixture and incubation continued for an additional 45 min. The G-sorb was then washed two times with PBS containing 0.5% Triton-X 100, 0.25% deoxycholate, 0.5% SDS, 2 mM PMSF and crystallized BSA (5 mg/ml, ICN, Cleveland, OH). This was followed by four washes in the same buffer containing no BSA. In some experiments, no SDS was ihcluded in the reaction or washing buffers. Pellets were extracted with sample buffer and analyzed on 7.5% or 5-15% gradient polyacrylamide gels according to Laemmli (20) . The gels were then fixed, enhanced with Enhance (New England Nuclear) and fluorographed using Kodak XAR film in the presence of intensifying screens. The amount of antibody used was sufficient to immunoprecipitate -90% of the corresponding antigen as determined in preliminary sequential immunoprecipitation experiments.
Immunoprecipitations using MAb were done in a similar manner except that no SDS was included in any of the buffers. Endoglycosidase-H treatment of immunoprecipitates containing 35S-labeled beta subunit precursor was performed exactly as described (22) .
RNA isolation and analysis. Total cellular RNA and poly(A)+ RNA were isolated from EBV-transformed B cell lines derived from normals and patients (23, 24) . Total RNA was quantitated by absorbance at an optical density of 260 nm (I OD260 U = 40 ,g of RNA per ml). Total cellular RNA (-20 Mg) or poly(A)+ RNA from each subject were denatured with formaldehyde, subjected to agarose-gel electrophoresis, transferred to nitrocellulose filters, and hybridized with a 32P-labeled beta subunit-specific cDNA probe or with a 3P-labeled beta actin-specific probe (25) (Northern blot analysis) (26) . The beta subunit specific cDNA insert and the beta actin-specific 2 kb insert contained in plasmid pAl were labeled with 32P essentially as described (27) .
Results
Biosynthesis of the common beta subunit in normal and Leu-CAM deficient EBV-transformed B cells. When EBV-transformed B cells from normal individuals are pulsed with [35S]methionine for 90 min, and the detergent soluble fraction immunoprecipitated with rabbit anti-beta subunit antibody, a single precursor with an apparent molecular mass of 85 kD appeared (Fig. 3 A) . If SDS is omitted from the immunoprecipitation procedure, an additional band of 170 kD representing the LFA-1 precursor was also seen (not shown). After an 18-h chase the beta subunit precursor was chased to a 94-kD band (Fig. 3 A) . This band had an identical mobility to the beta subunit immunoprecipitated from 1251I surface labeled EBV-transformed cells (not shown). Endo-H treatment ofthe beta chain precursor reduced its molecular mass to 73 kD (Fig. 3 B) indicating that it already contains "high manriose" type oligosaccharides. The processing ofthe normal beta precursor in EBV cells to the "ma- Pt. 4 that the molecular mass of the beta subunit precursor is reduced from 85 kD (upper arrow) in the absence (left lane) of Endo-H to 73 kD (lower arrow) in its presence (right lane). Molecular weight markers (arrow heads) were the same used in (A).
"chase." These data suggest that under normal conditions, only a fraction of the precursor beta subunit matures.
A beta chain precursor of normal mobility was present in normal amounts in metabolically labeled EBV cells from patients with partial or complete Leu-CAM deficiency (Fig. 3 A) . In patient 1 (14) (with total [< 2%] lack of Leu-CAM surface expression), the beta precursor did not mature by 18 h and was eventually degraded (Fig. 3 A) . Longer chase periods (up to 48 h) did not result in a detectable mature form (not shown). In patient 4 (with partial deficiency), trace amounts of a mature beta subunit were detected (Fig. 3 A) in agreement with the small amounts of this antigen that were detected on the surface (2 and Fig. 1) . Results obtained in patients 2 and 3 were similar to those in patients 1 and 4, respectively (not shown). In all patients comparable amounts of 02-microglobulin were synthesized and surface expressed as in normal cells (legends to Figs. I and 3) .
Northern blot analysis ofbeta chain mRNA. To examine the possibility that Leu-CAM deficiency is due to a transcriptional defect resulting in synthesis ofan mRNA of abnormal mobility, total cellular and poly(A)+ RNA from normal and Leu-CAM deficient cells were subjected to Northern blot analysis using a single stranded beta subunit cDNA probe. A single species mRNA was present in all four patients that had a mobility on agarose gels similar to that derived from normal cells (Fig. 4 A and B).
Discussion
The present investigation was undertaken in order to study the biosynthesis of the beta subunit common to LFA-1, Mo 1, and Leu M5 in leukocytes from unrelated patients with the complete or incomplete forms of Leu-CAM deficiency. A previous study (12) on one ofthe patients studied here (patient 1) did not detect any beta precursor despite the presence of normal alpha precursor. It was concluded that Leu-CAM deficiency is secondary to a primary deficiency ofthe beta subunit. A similar conclusion was made in a follow-up study (13) . The studies reported here indicate that all four unrelated patients, including patient 1, synthesize a beta chain precursor that has a normal mobility on SDS PAGE and in amounts comparable to those present in control cells (Fig. 3) . Either little or no detectable maturation of the precursors to the surface expressed form occurs in patients with "partial" or "complete" form ofthe deficiency, respectively, suggesting that little or none reach the trans region of the Golgi complex (28) . The discrepant findings regarding the synthesis of the beta subunit in patient 1 in this study and in the study by Springer et al. (12) may be explained by the fact that TS18, the monoclonal antibody directed against the beta subunit used by Springer et al. does not seem to recognize the beta precursor in normal cells (6) .
The availability of a cDNA clone encoding for the common beta subunit allowed further probing into the molecular basis of Leu-CAM deficiency. The beta chain mRNA had an approximate size of 3.4 kb in normal cells. Leu-CAM-deficient cells also contained a single form ofmRNA that had normal mobility and appeared to be present in normal amounts, again indicating that Leu-CAM-deficient cells have the beta chain gene and that synthesis of an abnormal beta chain precursor is not 2°to a transcriptional defect resulting in mRNA of abnormal mobility on agarose gel electrophoresis. Similar analysis in other Leu-CAM-deficient patients will be necessary to determine if true RNA from all five individuals contained the same sized beta chain mRNA. The increase in beta chain mRNA noted in patient 4 (as compared with the control and the other patients) appears to be secondary to increased loading of RNA since a proportional increase in beta-actin mRNA is seen in the same sample. The ratios of radioactivity of the beta chain mRNA band to that of the 2-kb beta-actin mRNA band (as determined by densitometric scanning of the autoradiographs) were as follows: Cl, 0.92; P4, 1.17; P3, 1.01; PI, 1.64; and P2, 0.76. In the autoradiograph of panel 2, the higher band represents the remaining radioactivity associated with the beta chain mRNA that was not completely washed off before rehybridization with the 32P-beta-actin probe. differences in the amount of mRNA exist and ifthe defect could also arise from a gene deletion.
The nature of the defect that results in the arrest of maturation of the beta subunit in our Leu-CAM-deficient cells is unclear. Abnormal posttranslational processing has been observed in many other systems in which there were mutations in the structural genes for glycoproteins (29). Cells from Leu-CAM deficient patients do not have defects in the production, accumulation, or translation ofthe beta messenger RNAs, suggesting that the basic defect is a mutation affecting the normal movement of the beta chain from the rough endoplasmic reticulum to the Golgi complex. An analogous transport deficient mutation has been recently identified in humans with familial hypercholesterolemia resulting in a complete or partial surface expression of the LDL receptor (30) . A deletion involving [7] [8] [9] [10] [11] [12] (30) . This led to the hypothesis that a gatekeeper protein may exist that blocks the surface expression of proteins whenever their disulfide bonding patterns are incorrect (30) . Similar abnormality(ies) in the Leu-CAM beta subunit may underlie the defect(s) seen in some of these patients. Of potential interest in this regard, is the finding that the protein coding region of the beta chain of the Leu-CAM family also contains three repeating units of 30-40 amino acids, each containing eight cysteine residues (8) . Since the alpha and beta subunit precursors normally associate prior to their processing to the membrane expressed forms (6, and data not shown), it is also likely that distinct mutation(s) in the beta precursor may alter the ability of this synthesized abnormal protein to form stable alpha-beta complexes, thus resulting in the phenotypic variations observed in Leu-CAM membrane expression. Cloning and sequencing of beta subunit specific cDNAs from Leu-CAM deficient cells will be necessary to identify the defect(s) at the molecular level. These studies will also shed more light on the mechanisms controlling the processing and transport of surface membrane receptors and on the structural basis for leukocyte adhesion.
